The European Patent Office (EPO) has granted patent EP3455352B1, titled 'VARIANT POLYPEPTIDES WITH IMPROVED PERFORMANCE AND USE OF THE SAME'. This patent relates to specific variant polypeptides and their applications, with Carsten Andersen listed as the inventor. The grant was published on March 18, 2026, and is effective in numerous designated European states.

This is a patent grant notification, not a regulatory rule or guidance. It does not impose new compliance obligations on regulated entities. Companies operating in the biotechnology and pharmaceutical sectors should be aware of this patent for intellectual property and competitive landscape monitoring purposes. No specific actions or deadlines are associated with this notice.